Protease Activated Probes for Real-Time Ratiometric Imaging of Solid Tumors

• Published in: ACS central science Vol. 9; no. 5; pp. 1059 - 1069
• Main Authors: Faucher, Franco F., Liu, Kevin J., Cosco, Emily D., Widen, John C., Sorger, Jonathan, Guerra, Matteo, Bogyo, Matthew
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 24.05.2023
• Subjects: Breast cancer; Cameras; Cancer; Cancer therapies; Contrast agents; Contrast media; FDA approval; Fluorescent indicators; Light sources; Localization; Medical imaging; Modular systems; Ovarian cancer; Probes; Radiation; Real time; Sensitivity enhancement; Solid tumors; Substrates; Surgery; Surgical outcomes; Tomography; Tumors; Ultrasonic imaging
• ISSN: 2374-7943; 2374-7951
• DOI: 10.1021/acscentsci.3c00261

Surgery is the preferred treatment option for most solid tumors. However, inaccurate detection of cancer borders leads to either incomplete removal of malignant cells or excess excision of healthy tissue. While fluorescent contrast agents and imaging systems improve tumor visualization, they can suffer from low signal-to-background and are prone to technical artifacts. Ratiometric imaging has the potential to eliminate many of these issues such as uneven probe distribution, tissue autofluorescence, and changes in positioning of the light source. Here, we describe a strategy to convert quenched fluorescent probes into ratiometric contrast agents. Conversion of the cathepsin-activated probe, 6QC-Cy5, into a two-fluorophore probe, 6QC-RATIO, significantly improved signal-to-background in vitro and in a mouse subcutaneous breast tumor model. Tumor detection sensitivity was further enhanced using a dual-substrate AND-gate ratiometric probe, Death-Cat-RATIO, that fluoresces only after orthogonal processing by multiple tumor-specific proteases. We also designed and built a modular camera system that was coupled to the FDA-approved da Vinci Xi robot, to enable real-time imaging of ratiometric signals at video frame rates compatible with surgical workflows. Our results demonstrate that ratiometric camera systems and imaging probes have the potential to be clinically implemented to improve surgical resection of many types of cancer.